In vitro activity of clindamycin, doxycycline, and trimethoprim/sulfamethoxazole against clinical isolates of β-hemolytic Streptococcus spp. via BD Phoenix and broth microdilution

• Príomhchruthaitheoirí: Christian Cho (Údar), Ryan K Shields (Údar), Ellen G Kline (Údar), Thomas L. Walsh (Údar), Chelsea E. Jones (Údar), Karen Kasarda (Údar), Kelly Stefano (Údar), Matthew A. Moffa (Údar), Derek N. Bremmer (Údar)
• Formáid: LEABHAR
• Foilsithe / Cruthaithe: Cambridge University Press, 2023-01-01T00:00:00Z.
• Ábhair: article
• Rochtain ar líne: Connect to this object online.

We tested 85 isolates of β-hemolytic Streptococcus spp. against trimethoprim/sulfamethoxazole (TMP/SMX), clindamycin, and doxycycline by broth microdilution (BMD) and BD Phoenix. Susceptibility rates via BMD for TMP/SMX, clindamycin, and doxycycline were 100%, 85.5%, and 56.6%, respectively. TMP/SMX...